Table 1. Pretreatment clinicopathologic characteristics of the study population (n=850).
| n (%) | |
|---|---|
|
Gender | |
| Male | 678 (79.8) |
| Female |
172 (20.2) |
|
Localisation | |
| Oesophagus | 610 (71.8) |
| AEG I | 241 (28.4) |
| AEG II | 254 (29.9) |
| AEG III | 115 (13.5) |
| Gastric | 240 (28.2) |
| Gastric body | 94 (11.1) |
| Gastric antrum | 94 (11.1) |
| Total gastric carcinoma |
52 (6.1) |
|
Gradinga | |
| G1/2 | 217 (25.9) |
| G3/4 |
621 (74.1) |
|
Laurén classificationa | |
| Intestinal type | 436 (52.3) |
| Non-intestinal type |
397 (47.7) |
|
Signet ring cell cancera | |
| Yes | 221 (30.0) |
| No | 516 (70.0) |
Abbreviation: AEG=adenocarcinomas of the oesophagogastric junction.
a
Missing data in some cases.